Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
ENDRA Life Sciences Inc. Warrants

ENDRA Life Sciences Inc. Warrants (NDRAW) Stock Overview

Explore ENDRA Life Sciences Inc. Warrants’s financial performance, market position, analyst ratings, and future outlook.

NDRAW●NASDAQ
HealthcareMedical - Diagnostics & Research
$0.03
$0.02(150.00%)
U.S. Market opens in 12h 45m

ENDRA Life Sciences Inc. Warrants (NDRAW)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio-0.57
EPS (TTM)N/A
ROE-5.13%
Fundamental Analysis

AI Price Forecasts

1 Month$-0.10
3 Months$0.04
1 Year Target$0.02

NDRAW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of ENDRA Life Sciences Inc. Warrants (NASDAQ: NDRAW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, ENDRA Life Sciences Inc. Warrants's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of NDRAW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.02 for the NASDAQ listing.

Key metrics behind ENDRA Life Sciences Inc. Warrants's NASDAQ-traded stock include a P/E ratio of -0.57 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of NDRAW on the NASDAQ.

Price Performance (NASDAQ: NDRAW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
-76.92%
All-Time (Max) Change
-96.84%

Contact Information

NaN
NaN
NaN, NaN, DE, NaN

Company Facts

IPO DateJun 28, 2017
CountryUS

Frequently Asked Questions